Lumeran, Jerald Kurt D.

HRN: 21-74-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/16/2025
11/23/2025
IV DRIP
565mg
Q6
PCAP C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: